Effect of nimesulide-a preferential COX-2 inhibitor on arterial blood pressure, compared to ketoprofen.

Tomasz Saran, Wojciech Sodolski, Katarzyna Sodolska, Wit Cezary Danilkiewicz, Janusz Schabowski
{"title":"Effect of nimesulide-a preferential COX-2 inhibitor on arterial blood pressure, compared to ketoprofen.","authors":"Tomasz Saran,&nbsp;Wojciech Sodolski,&nbsp;Katarzyna Sodolska,&nbsp;Wit Cezary Danilkiewicz,&nbsp;Janusz Schabowski","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Clinical and experimental studies have shown that renal and cardiovascular effects of most selective COX-2 inhibitors (rofecoxib, celecoxib) are similar to other traditional NSAIDs (dual COX inhibitors). In these study the effect of nimesulide--preferential COX-2 inhibitor, administration on 24-hour blood pressure profile was investigated in 40 adult individuals on antihypertensive therapy with pain states caused by osteoartritis. Nimesulide was administered orally, twice a day at the conventional dose of 0.1 g for five days. In the next (or previous) 5 days the same patients were administered with ketoprofen at the dose of 0.05 g three times a day. On the last day of the NSAID administration period, 24-hour blood pressure monitoring was performed. Our results indicate no difference between nimesulide and ketoprofen effects on mean blood pressure values during antihypertensive therapy.</p>","PeriodicalId":8245,"journal":{"name":"Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina","volume":"59 2","pages":"261-7"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Clinical and experimental studies have shown that renal and cardiovascular effects of most selective COX-2 inhibitors (rofecoxib, celecoxib) are similar to other traditional NSAIDs (dual COX inhibitors). In these study the effect of nimesulide--preferential COX-2 inhibitor, administration on 24-hour blood pressure profile was investigated in 40 adult individuals on antihypertensive therapy with pain states caused by osteoartritis. Nimesulide was administered orally, twice a day at the conventional dose of 0.1 g for five days. In the next (or previous) 5 days the same patients were administered with ketoprofen at the dose of 0.05 g three times a day. On the last day of the NSAID administration period, 24-hour blood pressure monitoring was performed. Our results indicate no difference between nimesulide and ketoprofen effects on mean blood pressure values during antihypertensive therapy.

与酮洛芬相比,尼美舒利-一种优先的COX-2抑制剂对动脉血压的影响。
临床和实验研究表明,大多数选择性COX-2抑制剂(罗非昔布、塞来昔布)的肾脏和心血管作用与其他传统非甾体抗炎药(双COX抑制剂)相似。在这些研究中,尼美舒利- COX-2优先抑制剂,给药对24小时血压谱的影响在40成人降压治疗与骨关节炎引起的疼痛状态。尼美舒利口服,每日2次,常规剂量0.1 g,连用5天。在接下来(或之前)5天,同样的患者给予0.05 g的酮洛芬,每天3次。在NSAID给药期的最后一天,进行24小时血压监测。我们的研究结果表明尼美舒利和酮洛芬对抗高血压治疗期间平均血压值的影响没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信